Genesis Therapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
415 Grand Ave Ste 201, South San Francis...Phone Number
(650) 745-8872Website
www.genesistherapeutics.aiRevenue
$8.4 MillionIndustry
About Genesis Therapeutics
Genesis Molecular AI specializes in utilizing advanced artificial intelligence to facilitate small molecule drug discovery. The company combines cutting-edge AI technology with expert drug hunters to develop innovative medicines, leveraging their proprietary platforms Pearl and GEMS. They collaborate with major pharmaceutical partners such as Gilead and Incyte to enhance their drug discovery processes. Their focus is on solving complex challenges in drug development through a unique interdisciplinary approach.Explore more
Genesis Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Genesis Therapeutics
Compare insights from companies similar to Genesis Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Genesis Therapeutics
$8.4M
11-50
Private
$256.1M
2019
CT
Carl TilburyVice President, Business Development
Genesis Therapeutics Tech Stack
A closer look at the technologies used by Genesis Therapeutics
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genesis Therapeutics
Sign Up For FreeTo access detailed company insights
Genesis Molecular AI specializes in utilizing advanced artificial intelligence to facilitate small molecule drug discovery. The company combines cutting-edge AI technology with expert drug hunters to develop innovative medicines, leveraging their proprietary platforms Pearl and GEMS. They collaborate with major pharmaceutical partners such as Gilea... Read More
